Drug Master Files, manufacturer listings, and Electronic Common Technical Document (eCTD) submissions are foundational to regulatory compliance. Yet even experienced regulatory, quality, and operations...
The global Unique Device Identification (UDI) landscape is entering a critical enforcement phase — and 2026 will be a challenging year for medical device manufacturers operating in the European Union...
The FDA’s final rule, “Revising the National Drug Code Format and Drug Label Barcode Requirements,” establishes a uniform 12-digit format for FDA-assigned National Drug Codes (NDCs) ...
UDI product data is now due for specific scenarios (enforced as of December 8, 2022). Class I and Unclassified medical devices that are required to be labeled with a UDI code must submit product data...
LexisNexis Life Sciences Solutions and ONIX expand strategic alliance to guide pharma customers to market faster Professionals in the life sciences industry rely on unique regulatory affairs expertise...
As of today, U.S. Prescribing Information (USPI) must still be distributed to prescribing healthcare professionals in printed paper format. Despite ongoing discussions around digital transformation and electronic product information, the requirement for printed labeling remains in place under current federal law.
This means pharmaceutical manufacturers are still responsible for composing FDA-approved USPI content into print-ready documents for distribution. Even if electronic distribution becomes authorized by future legislation or regulation, printed versions will continue to be required for compliance and must be promptly available upon request, though the overall demand for printed copies is expected to decline.
The continued USPI print requirement underscores the importance of efficient, compliant labeling workflows.
LexisNexis Reed Tech helps manufacturers meet these obligations by:
As the industry transitions toward digital product information, LexisNexis Reed Tech Label Composition Service remains a vital solution, helping you stay compliant, maintain audit-readiness, and anticipate regulatory changes so your teams are always prepared for what’s next.